Pfizer, Merck in pact with Canada to deliver up to 1.5 million courses of COVID-19 pills
Dec. 03, 2021 2:32 PM ETPfizer Inc. (PFE), MRKBy: Dulan Lokuwithana, SA News Editor10 Comments
- The Canadian government has inked purchase agreements with Pfizer (NYSE:PFE) and Merck (NYSE:MRK) to buy up to 1.5 million courses of their COVID-19 pills, Filomena Tassi, Canada’s minister of public services and procurement, said on Friday.
- Per the terms, Merck (MRK) is expected to supply up to 500,000 courses of its COVID-19 pill, molnupiravir, which is currently under regulatory review in Canada. Pending approval, the government has an option to purchase 500,000 doses, additionally.
- “As soon as these drugs are authorized for use, the government will work on getting them to provinces and territories as quickly as possible so that health-care providers can help Canadians who need them most,” Global News reported quoting Tassi.
- On Wednesday, Pfizer (PFE) said that the company started a rolling New Drug Submission seeking approval for its oral COVID-19 treatment, PF-07321332, and ritonavir targeting at-risk adults with mild to moderate COVID-19.